Cell Signaling Technology

Product Pathways - Ca / cAMP / Lipid Signaling

Bisindolylmaleimide I, Hydrochloride #9841

MW Source Purity
448.95 Da

Western Blotting

Western Blotting

Western blot analysis of extracts from A172 cells, untreated or treated with indicated concentrations of Bisindolylmaleimide I for 30 minutes, followed by stimulation with 200 nM TPA for 10 minutes. The phosphorylation of PEA-15 was detected by using Phospho-PEA-15 (Ser104) Antibody #2776 (upper). PEA-15 Antibody #2780 was used as a loading control (lower). Bisindolylmaleimide I-mediated inhibition of TPA-induced PKC phosphorylation of PEA-15 at Ser104 is shown.

Sequence

Sequence

Bisindolylmaleimide I structure

Directions for Use

Bisindolylmaleimide I is supplied as 500 μg powder. Store at or below -20°C. Before use, dissolve powder in 0.28 ml DMSO to make a 4 mM bisindolylmaleimide I stock solution. For working concentrations of 2 μM-4 μM, dilute DMSO stock 1:2000 to 1:1000. Treat cells with the desired concentration for 30 minutes. Bisindolylmaleimide I is more stable as a powder than in solution; it is therefore recommended to dissolve as close as possible prior to use. Store solution at or below -20°C.

Background

Bisindolylmaleimide I (BIS) is a potent inhibitor of PKC (1,2). In vitro the IC50 of BIS is 10-20 nM for PKCα/β/γ and 100-200 nM for PKCδ/ε isoforms. The in vitro IC50 for PKCζ is about 6 μM, indicating that BIS is a very weak inhibitor for this isoform. In in vivo cellular assays the IC50 of BIS for PKC is between 0.2-2 μM (1,3).

  1. Toullec, D. et al. (1991) J. Biol. Chem. 266, 15771-15781.
  2. Martiny-Baron, G. et al. (1993) J. Biol. Chem. 268, 9194-9197.
  3. Heikkila, J. et al. (1993) Biochem. Biophys. Res. Commun. 197, 1185-1193.

Application References

Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!

Companion Products

Product Pathways

Drug Discovery Tools

Featured Technologies

Protein Classes